Avera Heart Hospital in Sioux Falls broke ground on a $21.5 million, three-story expansion, with diagnostic imaging and ...

A 41-year-old Singaporean woman has given birth to a healthy baby girl after undergoing a rare, high-risk fetal heart surgery ...

The cardiovascular repair and reconstruction devices market offers vast opportunities with advancements in minimally invasive ...

Total Revenue -- $86,000 was recognized in the third quarter from initial sales of nPulse Capital and Vibrance disposables ...

The facility at St Richard's in Chichester has been closed since January due to ventilation system issues. It would cost £2m to fix and take up to two years to complete, according to the University ...

Get the latest on Pulse Biosciences’ Q3 2025 earnings: commercial growth, FDA progress, and clinical trial updates in soft tissue and cardiac therapies.

Today’s cardiology leaders are navigating an era of strategic growth, innovation and access expansion. With shifting procedure sites, workforce constraints and reimbursement dynamics, cardiology ...

Pulse Biosciences Inc (PLSE) advances in market development with FDA approvals and initial revenues, despite facing increased ...

Hypertension can also raise the risk of other health problems, including kidney disease and dementia. The link between blood ...

For optimal 1-year results, in patients with prior coronary artery bypass grafting who need percutaneous coronary ...

When Giovanna Andrews recalls her traumatic labor, one of the worst things is remembering how her calls for help were ignored ...

On November 7, KB Securities analyzed that WSI is accelerating its two-track growth strategy, focusing on the development of medical AI robots and the ...